Direct and residual antimicrobial effect of 2% chlorhexidine gel, double antibiotic paste and chitosan- chlorhexidine nanoparticles as intracanal medicaments against Enterococcus faecalis and Candida albicans in primary molars: an in-vitro study.
Candida albicans
Chitosan nanoparticles
Chlorhexidine
Double antibiotic paste
Enterococcus faecalis
Intracanal medicaments
Primary molars
Journal
BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684
Informations de publication
Date de publication:
04 08 2023
04 08 2023
Historique:
received:
12
12
2022
accepted:
06
03
2023
medline:
7
8
2023
pubmed:
5
8
2023
entrez:
4
8
2023
Statut:
epublish
Résumé
Thorough disinfection of root canals in primary molars may be complicated by the complex root canal morphology. This in-vitro study aimed to compare direct and residual antimicrobial effect of 2% chlorhexidine (CHX) gel, 500 mg/ml double antibiotic paste (DAP) and chitosan-chlorhexidine nanoparticles (CS-CHX NPs) as intracanal medicaments against Enterococcus faecalis (E. faecalis) and Candida albicans (C. albicans) in primary molars. Mesial roots of 63 mandibular second primary molars were infected with E. faecalis and C. albicans. Teeth were divided into 9 groups: Ia: (CS-CHX NPs), IIa: (CHX), IIIa: (DAP), IVa: chitosan nanoparticles (CSNPs) in which medicaments were placed for 3 days, groups Ib: (CS-CHX NPs), IIb: CHX, IIIb: (DAP), IVb: (CSNPs) in which medicaments were placed for 7 days, and Group V (control): teeth were infected, irrigated with saline, and sampled 3- and 7-days post-infection. Microbiological samples were obtained after infection, 3, and 7 days after medicament placement and 7 days after medicament removal for both time points. One-way ANOVA, Tukey's post hoc test and paired t-test were used at p < 0.05. CS-CHX NPs had the highest anticandidal effect which was comparable to CHX and significantly higher than other medicaments (p < 0.001) at both time points. CS-CHX NPs had the highest effect against E. faecalis which was comparable to DAP and significantly higher than other medicaments (p < 0.001) at 3 days. All medicaments showed similar effect against E. faecalis after 7 days. The 7-days placement significantly increased the antimicrobial effect against both micro-organisms in all groups, except CS-CHX NPs which showed an insignificant increase. CS-CHX NPs showed the highest residual effect against both micro-organisms that increased with 7-days placement. CSNPs and CHX combination showed a synergistic effect against both micro-organisms. CS-CHX NPs displayed a higher effect at a shorter period compared to other medicaments, yet its residual effect was higher with 7-days placement.
Sections du résumé
BACKGROUND
Thorough disinfection of root canals in primary molars may be complicated by the complex root canal morphology. This in-vitro study aimed to compare direct and residual antimicrobial effect of 2% chlorhexidine (CHX) gel, 500 mg/ml double antibiotic paste (DAP) and chitosan-chlorhexidine nanoparticles (CS-CHX NPs) as intracanal medicaments against Enterococcus faecalis (E. faecalis) and Candida albicans (C. albicans) in primary molars.
METHODS
Mesial roots of 63 mandibular second primary molars were infected with E. faecalis and C. albicans. Teeth were divided into 9 groups: Ia: (CS-CHX NPs), IIa: (CHX), IIIa: (DAP), IVa: chitosan nanoparticles (CSNPs) in which medicaments were placed for 3 days, groups Ib: (CS-CHX NPs), IIb: CHX, IIIb: (DAP), IVb: (CSNPs) in which medicaments were placed for 7 days, and Group V (control): teeth were infected, irrigated with saline, and sampled 3- and 7-days post-infection. Microbiological samples were obtained after infection, 3, and 7 days after medicament placement and 7 days after medicament removal for both time points. One-way ANOVA, Tukey's post hoc test and paired t-test were used at p < 0.05.
RESULTS
CS-CHX NPs had the highest anticandidal effect which was comparable to CHX and significantly higher than other medicaments (p < 0.001) at both time points. CS-CHX NPs had the highest effect against E. faecalis which was comparable to DAP and significantly higher than other medicaments (p < 0.001) at 3 days. All medicaments showed similar effect against E. faecalis after 7 days. The 7-days placement significantly increased the antimicrobial effect against both micro-organisms in all groups, except CS-CHX NPs which showed an insignificant increase. CS-CHX NPs showed the highest residual effect against both micro-organisms that increased with 7-days placement.
CONCLUSION
CSNPs and CHX combination showed a synergistic effect against both micro-organisms. CS-CHX NPs displayed a higher effect at a shorter period compared to other medicaments, yet its residual effect was higher with 7-days placement.
Identifiants
pubmed: 37542254
doi: 10.1186/s12903-023-02862-x
pii: 10.1186/s12903-023-02862-x
pmc: PMC10401786
doi:
Substances chimiques
Chlorhexidine
R4KO0DY52L
Anti-Bacterial Agents
0
Chitosan
9012-76-4
Root Canal Irrigants
0
Calcium Hydroxide
PF5DZW74VN
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
296Informations de copyright
© 2023. The Author(s).
Références
Dent Traumatol. 2015 Oct;31(5):374-9
pubmed: 26040200
Int J Clin Pediatr Dent. 2013 Sep;6(3):171-7
pubmed: 25206217
Arch Oral Biol. 2016 Oct;70:88-93
pubmed: 27341460
Photomed Laser Surg. 2018 Apr;36(4):179-184
pubmed: 29480759
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Oct;102(4):544-50
pubmed: 16997123
J Endod. 2000 Nov;26(11):652-5
pubmed: 11469294
Braz Oral Res. 2017 Dec 18;31:e108
pubmed: 29267669
Molecules. 2022 Apr 04;27(7):
pubmed: 35408724
Int Endod J. 2004 May;37(5):311-9
pubmed: 15086752
Prim Dent J. 2016 May 1;5(2):84-89
pubmed: 28826437
Eur Endod J. 2021 Aug;6(2):205-210
pubmed: 34650016
J Endod. 2017 Aug;43(8):1332-1336
pubmed: 28578886
J Endod. 2018 Nov;44(11):1616-1625.e9
pubmed: 30241680
Int J Biomater. 2012;2012:632698
pubmed: 22829829
J Conserv Dent. 2013 Jan;16(1):65-70
pubmed: 23349580
J Conserv Dent. 2014 Jul;17(4):335-9
pubmed: 25125845
Drug Deliv. 2020 Dec;27(1):26-39
pubmed: 31833443
Crit Rev Oral Biol Med. 2004 Sep 01;15(5):308-20
pubmed: 15470268
J Endod. 2015 Jul;41(7):1081-4
pubmed: 25887806
Braz Dent J. 2013;24(2):89-102
pubmed: 23780357
J Endod. 2016 Feb;42(2):258-62
pubmed: 26577870
BMC Oral Health. 2014 May 13;14:53
pubmed: 24886335
J Endod. 2008 Dec;34(12):1515-20
pubmed: 19026885
J Endod. 2020 Aug;46(8):1032-1041.e7
pubmed: 32413440
Colloids Surf B Biointerfaces. 2007 Sep 1;59(1):24-34
pubmed: 17555948
J Indian Soc Pedod Prev Dent. 2018 Jul-Sep;36(3):268-272
pubmed: 30246748
J Clin Pediatr Dent. 2006 Spring;30(3):233-7
pubmed: 16683672
Aust Endod J. 2009 Apr;35(1):29-33
pubmed: 19452677
Microorganisms. 2020 Aug 26;8(9):
pubmed: 32858856
Int J Biol Macromol. 2017 Nov;104(Pt B):1866-1873
pubmed: 28545965
Dent Mater J. 2020 Jun 5;39(3):456-463
pubmed: 32037384
Materials (Basel). 2017 May 31;10(6):
pubmed: 28772963
Int J Clin Pediatr Dent. 2015 Sep-Dec;8(3):202-7
pubmed: 26628855
Dent Mater J. 2017 May 31;36(3):319-324
pubmed: 28228624
Front Microbiol. 2018 Jul 03;9:1371
pubmed: 30018599
PLoS One. 2017 Mar 31;12(3):e0174888
pubmed: 28362873
Saudi Dent J. 2019 Jul;31(3):360-366
pubmed: 31337941
Int J Mol Sci. 2021 Sep 06;22(17):
pubmed: 34502560
Braz Dent J. 2008;19(1):28-33
pubmed: 18438556
Clin Oral Investig. 2015 Nov;19(8):2059-66
pubmed: 25689981
J Endod. 2015 Jun;41(6):824-30
pubmed: 25892513
Arch Oral Biol. 1996 May;41(5):401-12
pubmed: 8809302
Int Endod J. 2021 Oct;54(10):1850-1860
pubmed: 34033685
Singapore Dent J. 2017 Dec;38:39-44
pubmed: 29229073
BMC Oral Health. 2020 Nov 25;20(1):339
pubmed: 33238961
Biomed Res Int. 2020 Feb 18;2020:2128473
pubmed: 32149086
Aust Dent J. 2021 Sep;66(3):262-269
pubmed: 33486770
Microsc Res Tech. 2019 May;82(5):494-500
pubmed: 30597714
Pediatr Dent. 1989 Sep;11(3):198-202
pubmed: 2638005
BMC Oral Health. 2022 Aug 16;22(1):354
pubmed: 35974361
J Appl Oral Sci. 2009 Nov-Dec;17(6):555-9
pubmed: 20027425
Pediatr Dent. 2020 Sep 15;42(5):337-349
pubmed: 33087217